PharmaCyte Biotech
PMCB
PMCB
26 hedge funds and large institutions have $1.58M invested in PharmaCyte Biotech in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
70% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 10
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.2K | |
| 2 | +$3.83K | |
| 3 | +$2.29K | |
| 4 |
MCA
Maryland Capital Advisors
Chester,
Maryland
|
+$68 |
| 5 |
Jones Financial Companies
Des Peres,
Missouri
|
+$4 |
Top Sellers
| 1 | -$226K | |
| 2 | -$54.4K | |
| 3 | -$37.4K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$36.7K |
| 5 |
BlackRock
New York
|
-$26.2K |